SDHC and leukemia: Although it is currently unknown if GATA-1S has a direct role in the alteration of the splicing machinery, our results clearly indicate that, along with unbalanced GATA-1 isoform ratio, aberrant expression of SDHC ASVs emerges as a leukemia-promoting factor.